Healthcare IT Today

Is Being a "Disruptor" Still a Good Thing? A Look at the 2026 Healthcare Disruptors List

The episode examines Alan Schubbridge’s 2026 Healthcare Disruptors List, probing why certain players were added, removed, or placed in a "waiting room" category. Schubbridge, a veteran marketer at Providence, uses the list as a conversation starter about which innovations truly reshape care and which are merely hype. Key insights include the addition of the American Rescue Plan (ARP) for its lobbying power and senior‑consumer influence, and the rise of direct‑to‑consumer primary‑care models buoyed by venture capital despite thin margins. CVS was dropped, while Best Buy Health and Salesforce linger in a holding pattern, reflecting uncertainty about their long‑term impact. Vaccine hesitancy re‑appears as a "negative disruptor," and healthcare unions, especially SEIU, are highlighted for escalating labor actions. Schubbridge emphasizes that "disruption isn’t just hype" and warns that vaccine hesitancy is a "negative disruption" straining resources. He notes ARP’s policy work and DTC primary care’s funding surge, yet cautions on sustainability given poor primary‑care economics. The discussion also underscores how unions can destabilize staffing and cost structures. For investors and providers, the list signals that the "disruptor" tag no longer guarantees success; due diligence must separate genuine, financially viable change from fleeting buzz. Anticipating labor unrest and addressing vaccine‑preventable disease spikes will be critical for maintaining capacity and profitability in 2026 and beyond.